Repro-Med Systems, Inc. (OTCMKTS:REPR) Director Joseph M. Jr. Manko purchased 57,000 shares of the company’s stock in a transaction that occurred on Tuesday, November 13th. The shares were purchased at an average price of $1.64 per share, for a total transaction of $93,480.00. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.
OTCMKTS:REPR opened at $1.58 on Thursday. Repro-Med Systems, Inc. has a 52-week low of $0.64 and a 52-week high of $1.80.
Repro-Med Systems (OTCMKTS:REPR) last released its quarterly earnings results on Wednesday, October 24th. The company reported $0.01 earnings per share (EPS) for the quarter. The firm had revenue of $4.55 million for the quarter.
Repro Med Systems, Inc designs, manufactures, and markets proprietary portable medical devices and supplies primarily for the ambulatory infusion market and emergency medical applications worldwide. The company offers mechanical infusion product FREEDOM infusion systems, which include the FREEDOM60 syringe infusion driver, the FreedomEdge syringe infusion driver, HIgH-Flo subcutaneous safety needle sets, RMS precision flow rate tubing, and RMS precision flow rate controller, as well as medical suction product RES-Q-VAC, a portable medical suction system.
Recommended Story: Google Finance Portfolio
Receive News & Ratings for Repro-Med Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Repro-Med Systems and related companies with MarketBeat.com's FREE daily email newsletter.